What’s Up with CUP?

<p>Sydney E. Schultz, PharmD, @SydneyPharmD identifies presentation, prognostic factors and pathology associated with cancer of unknown primary, reviews historical treatment approaches, and discusses the role for use of molecular profiling to guide treatment. </p> <p>Twitter: <a href='https://twitter.com/sydneypharmd'>@SydneyPharmD</a></p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>